Ajanta Pharma Schedules Analyst/Institutional Investor Meetings in September 2026
Ajanta Pharma Limited will hold investor meetings in September 2026. A one-on-one meeting is scheduled for September 16th as part of the Jefferies India Forum. The company will also attend the PL Capital Mid & Small Cap Conference on September 28th.
This is a standard disclosure of an investor relations activity. It does not involve any new material information, financial results, or strategic decisions that would significantly impact the company's stock price or operations.
The announcement is a routine disclosure of upcoming investor meetings and does not contain any new financial or business performance information that would indicate a positive or negative sentiment.
Ajanta Pharma Limited has announced the schedule for upcoming meetings with Analysts and Institutional Investors. These meetings are intended to provide updates and engage with the investment community.
The first meeting is scheduled for September 16th, 2026, and will be a one-on-one session as part of the Jefferies India Forum, taking place in Oberoi, New Delhi.
Following this, the company will participate in the PL Capital Mid & Small Cap Conference 2026 on September 28th, 2026, held at Trident, BKC. Ajanta Pharma has confirmed that discussions during these meetings will be based solely on previously disclosed information.
The company also noted that the schedule is subject to change due to unforeseen circumstances. Further details regarding any modifications will be communicated accordingly.
A plain-language summary of a public exchange filing by Ajanta Pharma Limited. Read the original for the full detail.